Please assess the completion status of the following clinical trial:

Trial Title: Dysport® Adult Upper Limb Spasticity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients - post stroke or brain injury~* Modified Ashworth Scale ≥ 2~* Ambulatory patients~Exclusion Criteria:~* Previous treatment with botulinum toxin of any type within 4 months prior to study entry for any condition~* Physiotherapy initiated less than 4 weeks before inclusion~* Previous surgery, alcohol, phenol in upper limb~* Neurological/neuromuscular disorders which may interfere with protocol evaluations

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Dysport 500 U (Type: EXPERIMENTAL): None
- Dysport 1000 U (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).